167 related articles for article (PubMed ID: 10536490)
1. [Complications of prevention and treatment of erythrocyte alloimmunization (case reports)].
Zizka Z; Calda P; Zlatohlávková B; Plavka R; Krofta L; Hrusková H; Zivný J; Kvasnicka J
Sb Lek; 1998; 99(2):111-7. PubMed ID: 10536490
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
[TBL] [Abstract][Full Text] [Related]
3. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization.
Van Kamp IL; Klumper FJ; Oepkes D; Meerman RH; Scherjon SA; Vandenbussche FP; Kanhai HH
Am J Obstet Gynecol; 2005 Jan; 192(1):171-7. PubMed ID: 15672021
[TBL] [Abstract][Full Text] [Related]
4. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
[TBL] [Abstract][Full Text] [Related]
5. Fetal transfusion for red blood cell alloimmunization in pregnancy.
Schumacher B; Moise KJ
Obstet Gynecol; 1996 Jul; 88(1):137-50. PubMed ID: 8684747
[TBL] [Abstract][Full Text] [Related]
6. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
van Kamp IL; Klumper FJ; Bakkum RS; Oepkes D; Meerman RH; Scherjon SA; Kanhai HH
Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine treatment of severe fetal erythroblastosis: intravascular transfusion with ultrasonic guidance.
Keckstein G; Stoz F; Tschürtz S; Terinde R; Jonatha WD; Lauritzen C
J Perinat Med; 1989; 17(5):341-9. PubMed ID: 2696779
[TBL] [Abstract][Full Text] [Related]
8. Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization.
Deka D; Dadhwal V; Sharma AK; Shende U; Agarwal S; Agarwal R; Vanamail P
Arch Gynecol Obstet; 2016 May; 293(5):967-73. PubMed ID: 26493554
[TBL] [Abstract][Full Text] [Related]
9. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
de Haan TR; van den Akker ES; Porcelijn L; Oepkes D; Kroes AC; Walther FJ
BJOG; 2008 Jan; 115(1):76-81. PubMed ID: 18053103
[TBL] [Abstract][Full Text] [Related]
11. [Results and complications of intrauterine transfusion in fetuses with and without hydrops].
Hájek Z; Kulovaný E; Liska K; Prokop M; Koleska T; Drbohlav P
Ceska Gynekol; 1996 Feb; 61(1):31-5. PubMed ID: 8624593
[TBL] [Abstract][Full Text] [Related]
12. [Report of experiences in 20 years use of intrauterine fetal transfusion in severe Rh-induced hemolytic disease of newborn].
Schwarzlos G; Stark KH; During R; Hille M; Müller S; Plesse R; Scheunemann P; Wilken H
Zentralbl Gynakol; 1988; 110(1):18-24. PubMed ID: 3354274
[TBL] [Abstract][Full Text] [Related]
13. Sonographic demonstration of brain injury in fetuses with severe red blood cell alloimmunization undergoing intrauterine transfusions.
Ghi T; Brondelli L; Simonazzi G; Valeri B; Santini D; Sandri F; Ancora G; Pilu G
Ultrasound Obstet Gynecol; 2004 May; 23(5):428-31. PubMed ID: 15133789
[TBL] [Abstract][Full Text] [Related]
14. Intravascular intrauterine transfusion for severe erythroblastosis fetalis using different techniques.
Orsini LF; Pilu G; Calderoni P; Zucchini S; Tripoli N; Pittalis MC; Brondelli L; Gabrielli S; Sermasi G; Bovicelli L
Fetal Ther; 1988; 3(1-2):50-9. PubMed ID: 3257067
[TBL] [Abstract][Full Text] [Related]
15. [Rh-incompatibility acidosis in newborn infants following intrauterine transfusion].
Siebers JW
Geburtshilfe Frauenheilkd; 1985 Aug; 45(8):552-3. PubMed ID: 4043707
[TBL] [Abstract][Full Text] [Related]
16. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
[TBL] [Abstract][Full Text] [Related]
17. Current clinical management of anti-Kell alloimmunization in pregnancy.
Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
[TBL] [Abstract][Full Text] [Related]
18. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.
Weiner CP; Williamson RA; Wenstrom KD; Sipes SL; Widness JA; Grant SS; Estle L
Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1302-7. PubMed ID: 1957851
[TBL] [Abstract][Full Text] [Related]
19. [Transfusion-induced acid load caused by erythrocyte concentrates in the newborn].
Abel M; Fürste HO; Pringsheim W; Sievers JW; Otto J
Infusionsther Klin Ernahr; 1984 Oct; 11(5):267-9. PubMed ID: 6511085
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of severe Rhesus erythroblastosis].
Bichler A; Frisch H
Padiatr Padol; 1977; 12(4):339-48. PubMed ID: 409979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]